Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jingulian capsule for knee osteoarthritis pain and function
ChiCTR2400091229Phase 4Not yet recruiting
- Sponsor
- Hospital Affiliated to Changchun University of Traditional Chinese Medicine
- Start
- Oct 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in knee osteoarthritis (OA) comparing Celecoxib + Jingulian capsule with Celecoxib + Jingulian placebo (2 arms). Primary endpoint: WOMAC knee function score. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
Jingulian Capsule
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2400091229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091229.